Selegiline for Smoking Cessation - 1

NCT00439413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

246

Enrollment

NIH

Sponsor class

Conditions

Nicotine Dependence

Interventions

DRUG: Selegiline Transdermal Patch
DRUG: Placebo
BEHAVIORAL: Smoking Cessation Counseling

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]